Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Co-danthramer
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-danthramer 25mg/200mg/5ml oral suspension sugar free
0106020B0AAAAAA
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | 201 |
|
Co-danthramer 75mg/1000mg/5ml oral suspension sugar free
0106020B0AAABAB
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | 16 |
|
Co-danthramer 25mg/200mg capsules
0106020B0AAACAC
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Co-danthramer 25mg/200mg/5ml oral suspension
0106020B0AAAHAH
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Co-danthramer 37.5mg/500mg capsules
0106020B0AAAFAF
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.